Idiopathic pulmonary fibrosis trials in Mexico

4 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.

• Phase 2Not yet taking people in Mexico
  A Study to Test Whether BI 3810477 Helps People With Idiopathic Pulmonary Fibrosis When Taken With or Without Standard Treatment

  Where

  Distrito Federal, León, Monterrey, Nuevo León

  Age

  40 years and over

  People

  70 worldwide

  Run by

  Boehringer Ingelheim

  See details and how to joinNCT07926321 · EU 2026-527098-13-00
• Phase 3Not yet taking people in Mexico
  Long-term Extension Study to Evaluate Safety and Tolerability of Admilparant in Participants With Pulmonary Fibrosis

  Where

  Aguascalientes, Chihuahua City, Col Garcia Binersa, Guadalajara, Mérida, Metepec, México, Monterrey, Morelia, Oaxaca City

  Age

  18 years and over

  People

  2,380 worldwide

  Run by

  Bristol-Myers Squibb

  See details and how to joinNCT07441408 · EU 2025-522373-10-00
• Phase 2Taking people
  A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.

  Where

  Benito Juárez, Chihuahua City, Coyocan, León, Mérida, Monterrey, Oaxaca City, Pachuca

  Age

  40 years and over

  People

  359 worldwide

  Run by

  AstraZeneca

  See details and how to joinNCT07652658
• Phase 3Enrolling by invitation
  Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease

  Where

  Mexico City, Monterrey

  Age

  40 years and over

  People

  1,850 worldwide

  Run by

  United Therapeutics

  See details and how to joinNCT04905693